Navamedic ASA (FRA:N1A) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA 3-Year EBITDA Growth Rate?

Navamedic ASA's EBITDA per Share for the six months ended in Dec. 2023 was €0.10.

During the past 12 months, Navamedic ASA's average EBITDA Per Share Growth Rate was -41.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Navamedic ASA was 45.40% per year. The lowest was -198.40% per year. And the median was 15.10% per year.

Competitive Comparison of Navamedic ASA's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Navamedic ASA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navamedic ASA's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's 3-Year EBITDA Growth Rate falls into.

Navamedic ASA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Navamedic ASA (FRA:N1A) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Navamedic ASA 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Navamedic ASA (FRA:N1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

NAVA:Norway

Address

Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255

Website

https://www.navamedic.com

Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines